The Stimulus Bill and Funding Opportunities for Cleantech Startups

loan guarantees for renewable energy and transmission projects. There are three product categories: renewable energy systems; electric power transmission systems; and cutting-edge biofuel projects. DOE has already administered an innovative technology program under Title VII of the Energy Policy Act. These new funds will expand that program significantly and make it easier to use.

Because the recovery act is so new, most agencies have not had an opportunity to issue implementing regulations or guidance documents explaining program eligibility requirements and the process of taking advantage of them. However, there is enormous pressure on these agencies to move quickly because these funds are viewed as essential to economic recovery. There also are many deadlines included in act, which only compounds such pressure.

We’ve developed a few recommendations to help cleantech startups and VCs get with the program. Applicants for these funds should be prepared to comply with the restrictions of the programs and to understand that the government may request an ownership or licensing agreement in return for providing funding. Possibilities include the potential government ownership of any developed intellectual property, retaining march-in Rights (the ability to require licensing or to license third parties on its own), or the receipt of a non-exclusive, royalty-free license. Interested companies should:

—Review the eligibility criteria of the programs and monitor carefully the guidance on new programs which will be issued over the next few weeks and months;
—Consider retaining an experienced grant writer, who can properly address the often complex application requirements;
—Consult with legal counsel to assess potential intellectual property and tax issues; and
—Create in-house mechanisms to benchmark the project and track the funding, particularly since grant programs require detailed reporting on the use and results of the funded initiative.

Startups can often improve the odds of getting government funding by securing support among key senior officials within the White House or other agencies of the Executive Branch as well as members of Congress and their staffs. The California Congressional delegation has historically been interested in the development of technology and many members of the delegation are in key positions to support such efforts. When pursuing funding opportunities, it is essential for companies to explain why their technology deserves funding and the specific benefits the initiative aims to produce. It also is useful to review case studies of successful coalitions to find out what strategies were followed. And finally, the government is placing a premium on projects that can begin construction as soon as possible.

Author: Scott N. Wolfe

Scott Wolfe is a partner in the San Diego office of Latham & Watkins. Mr. Wolfe advises start-up and emerging businesses and public companies, particularly in the life sciences and high-technology industries. He regularly represents companies and investment banking firms in public offerings, private placements, venture capital financings, real estate investment trusts, debt offerings, corporate partnering arrangements, and mergers and acquisitions. Mr. Wolfe is a member of the American, California and San Diego Bar Associations. He is the former Chairman and current trustee and member of the Executive Committee of Rady Children's Hospital and Health Center in San Diego. He is a trustee of BIOCOM, CONNECT and the Corporate Directors Forum, Counsel for the Sanford Consortium of Regenerative Medicine and member of the Dean's Advisory Council of the Rady School of Management at UCSD. Mr. Wolfe is a former owner of the San Diego Padres (1990–1999). He is an Adjunct Professor of Law at USD Law School teaching a class in “Advanced Corporate Transactional Skills” and teaches classes in venture capital and mergers and acquisitions at the Rady School. Mr. Wolfe is a recommended as a “leading lawyer” in Chambers USA 2014 – Capital Markets: Debt & Equity – California and in Life Sciences: California and is described as "extremely experienced and very bright; there is really not a lot that you can come up against that he hasn't been involved in." He is the recipient of the 2013 Thomas F. Carter Award, the highest leadership and philanthropic award given by Rady Children’s Hospital and Health Center – San Diego, and was named as one of the “important M&A practitioners” by The Legal 500 US.